PetrarcaC.FrydasS.DonelanJ.BoucherW.PapadopoulouN.CaoJ.CastellaniM.L.ContiP.ToniatoE.RobuffoI.VecchietJ.IezziT.MadhappanB.KempurajD., 2005. Interleukin 27 (IL-27): A novel pleiotropic cytokine involved in T cell differentiation and T cell response modulation. Int. J. Immunopathol. Pharmacol.18:191.
2.
MussoT.CappelloP.StornelloS.RavarinoD.CaorsiC.OteroK.NovelliF.BadolatoR.GiovarelliM., 2005. IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytes. Int. J. Immunopathol. Pharmacol.18:339.
3.
Di GiannantonioM.FrydasS.KempurajD.KaragouniE.HatzistilianouM.ContiC.M.V.BoucherW.PapadopoulouN.DonelanJ.CaoJ.MadhappanB.BoscoloP.PetrarcaC.CastellaniL.QuartesanR.DoyleR.FerroF.M., 2005. Cytokines in stress. Int. J. Immunopathol. Pharmacol.18:1.
4.
AlexandrakisM.G.PassamF.H.PappaC.A.DamilakisJ.TsirakisG.KandidakiE.StathopoulosE.N.KyriakouD.S., 2005. Serum evaluation of angiogenic cytokines basic fibroblast growth factor, hepatocyte growth factor and TNF-α in patients with myelodysplastic syndromes: Correlation with bone marrow microvascular density. Int. J. Immunopathol. Pharmacol.18:287.
5.
PelletierM.BouchardA.GirardD., 2004. In vivo and in vitro roles of IL-21 in inflammation. J. Immunol.173:7521.
6.
GorbunovN.V.McFaulS.J.JanuszkiewiczA.AtkinsJ.L., 2005. Proinflammatory alterations and status of blood plasma iron in a model of blast-induced lung trauma. Int. J. Immunopathol. Pharmacol.18:547.
7.
TotaroR.PassacantandoA.RussoT.ParzaneseI.RascenteM.MariniC.ToniettiG.CaroleiA., 2005. Effects of interferon beta, cyclophosphamide, and azathioprine on cytokine profile in patients with multiple sclerosis. Int. J. Immunopathol. Pharmacol.18:377.
8.
MatalonR.SurendranS.McDonaldJ.D.OkoroduduA.O.TyringS.K.Michals-MatalonK.HarrisP., 2005. Abnormal expression of genes associated with development and inflammation in the heart of mouse maternal phenylketonuria offspring. Int. J. Immunopathol. Pharmacol.18:557.
9.
StrengellM.SarenevaT.FosterD.JulkunenI.MatikainenS., 2002. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J. Immunol.169:3600.
10.
YamakiK.UchidaHLiX.YanagisawaR.TakanoH.HayashiH.MoriY.YoshinoS., 2005. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol.18:133.
11.
FalkensammerB.FasserW.SchererK.ZemannA.ParsonW.UlmerH.DierichM.P.StoiberH., 2005. Drug monitoring and viral response to lopinavir/ritonavir or saquinavir/ritonavir containing regimens in individuals infected with the Human Immunodeficiency Virus Type 1. Int. J. Immunopathol. Pharmacol.18:145.
12.
LeonardW.J.SpolskiR., 2005. Interleukin-21: A modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol.5:688.
13.
MartiniF.AgratiC.D'OffiziG.PocciaF., 2005. HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells. Int. J. Immunopathol. Pharmacol.18:269.
14.
CognasseF.ChavarinP.AcquariS.SapidoO.BeniguelL.GeninC.RichardY.GarraudO., 2005. Differential downstream effects of ligation mediated by membrane or soluble CD40L and agnostic Ab: A study on purified human B cells. Int. J. Immunopathol. Pharmacol.18:65.
15.
EspositoI.PernaF.PonticielloA.PerrellaM.GilliM.SanduzziA., 2005. Natural Killer cells in BAL and peripheral blood of patients with idiopathic pulmonary fibrosis (IPF). Int. J. Immunopathol. Pharmacol.18:541.
16.
Parrish-NovakJ.DillonS.R.NelsonA.HammondA.SprecherC.GrossJ.A., 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature408:57.
17.
LanzilliG.FalchettiR.TricaricoM.UngheriD.FuggettaM.P., 2005. In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int. J. Immunopathol. Pharmacol.18:245.
18.
KaragouniE.AthanassopoulouF.TsagozisP.RalliE.MoustakareasT.LytraK.DotsikaE., 2005. The impact of a successful anti-myxosporean treatment on the phagocyte functions of juvenile and adult Sparus Aurata L. Int. J. Immunopathol. Pharmacol.18:121.
19.
ZengR.SpolskiR.FinkelsteinS.E.OhS.KovanenP.E.HinrichsC.S., 2005. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med.201:139.
20.
SommaP.Lo MuzioL.MansuetoG.DelfinoM.FabbrociniG.MascoloM.MignognaC.Di BenedettoM.CarinciF.SerpicoR.De RosaG.StaibanoS., 2005. Squamous cell carcinoma of the lower lip: Fas/FasL expression, lymphocyte subtypes and outcome. Int. J. Immunopathol. Pharmacol.18:59.
21.
MarinovaS.NenkovP.MarkovaR.NikolaevaS.KostadinovaR.MitovI.VretenarskaM., 2005. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int. J. Immunopathol. Pharmacol.18:457.
22.
CollinsM.WhittersM.J.YoungD.A., 2003. IL-21 and IL-21 receptor: A new cytokine pathway modulates innate and adaptive immunity. Immunol. Res.28:131.
23.
GaldieroM.PisciottaM.G.GorgaF.PetrilloG.MarinelliA.GaldieroE., 2005. Modulation of costimulating molecules CD80/CD86 on B cells and macrophages by stress proteins GroEL, GroES and Dna K. Int. J. Immunopathol. Pharmacol.18:637.
24.
AvgerinosD.V.TheoharidesT.C., 2005. Mesenteric traction syndrome or gut in distress. Int. J. Immunopathol. Pharmacol.18:195.
25.
HabibT.SenadheeraS.WeinbergK.KaushanskyK., 2002. The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry41:8725.
26.
BrunettiL.Di NisioC.OrlandoG.FerranteC.VaccaM., 2005. The regulation of feeding: A cross talk between peripheral and central signalling. Int. J. Immunopathol. Pharmacol.18:201.
27.
BalleriniP.CiccarelliR.CaciagliF.RathboneM.P.WerstiukE.S.TraversaU.BuccellaS.GiulianiP.JiangS.NargiE.VisiniD.SantavenereC.Di IorioP., 2005. P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes. Int. J. Immunopathol. Pharmacol.18:417.
28.
HabibT.NelsonA.KaushanskyK., 2003. IL-21: A novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J. Allergy Clin. Immunol.112:1033.
29.
BernardiniR.MistrelloG.NovembreE.RoncaroloD.ZanottaS.LombardiE.CianferoniA.PucciN.De MartinoM.VierucciA., 2005. Cross-reactivity between IgE-binding proteins from Anisakis simplex and Dermatophagoides pteronyssinus. Int. J. Immunopathol. Pharmacol.18:671.
30.
BalleriniP.Di IorioP.CiccarelliR.CaciagliF.PoliA.BeraudiA.BuccellaS.D'AlimonteI.D'AuroM.NargiE.PatricelliP.VisiniD.TraversaU., 2005. P2Y1 and cysteinyl-leukotriene receptors mediate purine and cysteinyl-leukotriene co-release in primary cultures of rat microglia. Int. J. Immunopathol. Pharmacol.18:255.
31.
BonsiL.PierdomenicoL.BiscardiM.MarchionniC.GavazziS.FossatiV.GhinassiB.AlvianoF.RondelliD.FranchinaM.BagnaraG.P.GrossiA., 2005. Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: Effect on proliferation and signaling pathway. Int. J. Immunopathol. Pharmacol.18:445.
32.
BenczikM.GaffenS.L., 2004. The interleukin (IL)-2 family cytokines: Survival and proliferation signalling pathways in T lymphocytes. Immunol. Invest.33:109.
33.
Appert-CollinA.DuongF.H.T.DegraceP. PassillyWarterJ.M.PoindronP.GiesJ.P., 2005. MAPK activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of xaliproden. Int. J. Immunopathol. Pharmacol.18:2.
34.
CenturioneL.Di GiulioC.SantavenereE.CacchioM.SabatiniN.RapinoC.BianchiG.RapinoM.BoscoD.AntonucciA.CataldiA., 2005. Protein kinase C zeta regulation of hypertrophic and apoptotic events occurring during rat neonatal heart development and growth. Int. J. Immunopathol. Pharmacol.18:49.
35.
HerrinB.R.JustementL.B., 2006. Expression of the adaptor protein hematopoietic Src homology 2 is up-regulated in response to stimuli that promote survival and differentiation of B cells. J. Immunol.176:4163.
36.
CaproniM.TorchiaD.AntigaE.Degl'InnocentiD.BarlettaE.BaroniG.SantucciM.FabbriP., 2005. The role of apoptosis in the pathogenesis of dermatitis herpetiformis. Int. J. Immunopathol. Pharmacol.18:691.
37.
GonzalezM.I.RubinsteinN.IlarreguiJ.M.ToscanoM.A.SanjuanN.A.RabinovichG.A., 2005. Regulated expression of Galectin-1 after in vitro productive infection with herpes simplex virus type I: Implications for T cell apoptosis. Int. J. Immunopathol. Pharmacol.18:615.
38.
OttonelloL.BertolottoM.MontecuccoF.DapinoP.DallegriF., 2005. Dexamethasone-induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95- and XIAP-dependent pathways. Int. J. Immunopathol. Pharmacol.18:403.
39.
VinuesaC.G.CookM.C.AngelucciC.AthanasopoulosV.RuiL.HillK.M.YuD.DomaschenzH.WhittleB.LambeT.RobertsI.S.CopleyR.R.BellJ.I.CornallR.J.GoodnowC.C., 2005. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature435:452.
40.
GallegosA.M.BevanM.J., 2004. Driven to autoimmunity: The nod mouse. Cell117:149.
41.
PerrellaA.BorgiaG.BorrelliF.Di SirioS.GnariniM.GrattacasoS.GrafM.GuidaM.ViolaC.GuarnacciaM.PerrellaO., 2005. TNF-α serum level elevations in chronic hepatitis C patients with diabetes mellitus. Int. J. Immunopathol. Pharmacol.18:189.
42.
GuidiL.CostanzoM.CiarnielloM.De VitisI.PioliC.GattaL.PaceL.TricerriA.BartoloniC.CoppolaL.BalistreriP.DoriaG.FedeliG.GasbarriniG.B., 2005. Increased levels of NF-kB inhibitors (IκBα and IκBγ) in the intestinal mucosa of Crohn's disease patients during infliximab treatment. Int. J. Immunopathol. Pharmacol.18:155.
43.
LicastroF.ChiappelliM.RuscicaM.CarnelliV.CorsiM.M., 2005. Altered cytokine and acute phase response protein levels in the blood of children with Down's syndrome: Relationship with dementia of Alzheimer's type. Int. J. Immunopathol. Pharmacol.18:165.
44.
KovanenP.E.LeonardW.J., 2004. Cytokines and immunodeficiency diseases: Critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev.202:67.
45.
MaH.L.WhittersM.J.KonzR.F.SenicesM.YoungD.A.GrusbyM.J., 2003. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. J. Immunol.171:608.
46.
WangG.TschoiM.SpolskiR.LouY.OzakiK.FengC., 2003. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res. 63:9016.
47.
Di CarloE.ComesA.OrengoA.M.RossoO.MeazzaR.MusiniP., 2004. IL-21 induces tumor rejection by specific CTL and IFNgamma-dependent CXC chemokines in syngeneic mice. J. Immunol.172:1540.
48.
SessaR.SchiavoniG.Di PietroM.PetruccaA.CiprianiP.ZagagliaC.FalluccaS.del PianoM., 2005. Chlamydia pneumoniae in PBMC: Reproducibility of the ompa nested touchdown PCR. Int. J. Immunopathol. Pharmacol.18:113.
49.
FrydasS.PapaioannouN.PapazahariadouM.HatzistylianouM.KaragouniE.TrakatelliM.BrellouG.PetrarcaC.CastellaniM.L.ContiP.RiccioniG.GrilliA., 2005. Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: Effect of the anti-inflammatory compound 1-mimosine. Int. J. Immunopathol. Pharmacol.18:85.